arrow
L

Lynn Quek

king's college london
H指数:29
被引数:6,607

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

SLIT2 modulates leukaemic cell proliferation and stromal support in acute myeloid leukaemia models

SLIT2调节急性髓系白血病模型中白血病细胞的增殖和基质支持

2026-09-290
PRE
Metformin induces ferroptosis associated with lipidomic remodeling in AML

二甲双胍诱导与脂质组重塑相关的铁死亡在AML中

2025-11-040
OAAI
High mtDNA content identifies oxidative phosphorylation-driven acute myeloid leukemias and represents a therapeutic vulnerability

高mtDNA含量可识别氧化磷酸化驱动的急性髓性白血病,并代表治疗脆弱性

2025-07-140
OAAI
Ethnic variations in neutrophil count as predictors of prognosis following acute myocardial infarction

中性粒细胞计数中的种族差异作为急性心肌梗死后预后的预测因子

2025-04-010
OAAI
DGATI Inhibition Enhances Metformin-Induced Ferroptosis in AML By Targeting Lipid Metabolism

DGATI 抑制通过靶向脂质代谢增强二甲双胍诱导的AML中铁死亡

BLOOD
IF23.1
2024-11-051
PRE
The Oncogenic Function of the Intrinsically Disordered Transcriptional Regulator MN1 Depends on the Chaperone DNAJB6b

内源无序转录调控因子MN1的致癌功能依赖于分子伴侣DNAJB6b

BLOOD
IF23.1
2024-11-050
PRE
M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism
2023-04-1418
OAAI
Chromatin accessibility governs the differential response of cancer and T cells to arginine starvation
2021-05-0127
OAAI
Integrating clinical features with genetic factors enhances survival prediction for adults with acute myeloid leukemia
2020-05-2612
OAAI
Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AML
2020-05-07145
OAAI
TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups
LEUKEMIA
IF13.4
2019-01-11177
OAAI
Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib
2018-07-16146
OAAI